Fremanezumab, AJOVY 225 mg solution for injection in pre-filled pen
TV48125-CNS-30084
Phase 3 small_molecule active
Quick answer
Fremanezumab, AJOVY 225 mg solution for injection in pre-filled pen for Episodic and Chronic Migraine is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Episodic and Chronic Migraine
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active